© Reuters. FILE PHOTO: A pharmacist displays a box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes made by Lilly at Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. REUTERS/George Frey/File photo
Wegovy and Mounjaro, both administered once weekly, are part of a class of drugs called GLP-1 receptor agonists originally developed for type 2 diabetes, which suppress appetite. Three sources familiar with the matter said the site would handle GLP-1 business. They would not name the client, but Thermo is already filling Wegovy pens for Novo in North Carolina.FUJIFILM Diosynth Biotechnologies, a subsidiary of Japan's Fujifilm Corp, expects to announce by the end of this year a major contract with a company for sterile fill-finish work at its expanded facilities in Texas and Denmark, CEO Lars Petersen told Reuters.